147 related articles for article (PubMed ID: 22989413)
1. Intracerebroventricular injection of orexin-2 receptor antagonist promotes REM sleep.
Kummangal BA; Kumar D; Mallick HN
Behav Brain Res; 2013 Jan; 237():59-62. PubMed ID: 22989413
[TBL] [Abstract][Full Text] [Related]
2. Selective stimulation of orexin receptor type 2 promotes wakefulness in freely behaving rats.
Akanmu MA; Honda K
Brain Res; 2005 Jun; 1048(1-2):138-45. PubMed ID: 15919057
[TBL] [Abstract][Full Text] [Related]
3. Promotion of sleep by targeting the orexin system in rats, dogs and humans.
Brisbare-Roch C; Dingemanse J; Koberstein R; Hoever P; Aissaoui H; Flores S; Mueller C; Nayler O; van Gerven J; de Haas SL; Hess P; Qiu C; Buchmann S; Scherz M; Weller T; Fischli W; Clozel M; Jenck F
Nat Med; 2007 Feb; 13(2):150-5. PubMed ID: 17259994
[TBL] [Abstract][Full Text] [Related]
4. Discovery of a potent, CNS-penetrant orexin receptor antagonist based on an n,n-disubstituted-1,4-diazepane scaffold that promotes sleep in rats.
Whitman DB; Cox CD; Breslin MJ; Brashear KM; Schreier JD; Bogusky MJ; Bednar RA; Lemaire W; Bruno JG; Hartman GD; Reiss DR; Harrell CM; Kraus RL; Li Y; Garson SL; Doran SM; Prueksaritanont T; Li C; Winrow CJ; Koblan KS; Renger JJ; Coleman PJ
ChemMedChem; 2009 Jul; 4(7):1069-74. PubMed ID: 19418500
[TBL] [Abstract][Full Text] [Related]
5. Blockade of orexin-1 receptors attenuates orexin-2 receptor antagonism-induced sleep promotion in the rat.
Dugovic C; Shelton JE; Aluisio LE; Fraser IC; Jiang X; Sutton SW; Bonaventure P; Yun S; Li X; Lord B; Dvorak CA; Carruthers NI; Lovenberg TW
J Pharmacol Exp Ther; 2009 Jul; 330(1):142-51. PubMed ID: 19363060
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of a dual orexin receptor antagonist (SB-649868) and zolpidem on sleep initiation and consolidation, SWS, REM sleep, and EEG power spectra in a model of situational insomnia.
Bettica P; Squassante L; Groeger JA; Gennery B; Winsky-Sommerer R; Dijk DJ
Neuropsychopharmacology; 2012 Apr; 37(5):1224-33. PubMed ID: 22237311
[TBL] [Abstract][Full Text] [Related]
7. Antagonism of rat orexin receptors by almorexant attenuates central chemoreception in wakefulness in the active period of the diurnal cycle.
Li A; Nattie E
J Physiol; 2010 Aug; 588(Pt 15):2935-44. PubMed ID: 20547681
[TBL] [Abstract][Full Text] [Related]
8. Effects of orexins A and B on expression of orexin receptors and progesterone release in luteal and granulosa ovarian cells.
Cataldi NI; Lux-Lantos VA; Libertun C
Regul Pept; 2012 Oct; 178(1-3):56-63. PubMed ID: 22749989
[TBL] [Abstract][Full Text] [Related]
9. Locus Coeruleus and Tuberomammillary Nuclei Ablations Attenuate Hypocretin/Orexin Antagonist-Mediated REM Sleep.
Schwartz MD; Nguyen AT; Warrier DR; Palmerston JB; Thomas AM; Morairty SR; Neylan TC; Kilduff TS
eNeuro; 2016; 3(2):. PubMed ID: 27022631
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of orexin type 2 receptor in the lateral pontomesencephalic tegmentum of rats increases REM sleep.
Chen L; McKenna JT; Bolortuya Y; Brown RE; McCarley RW
Eur J Neurosci; 2013 Mar; 37(6):957-63. PubMed ID: 23282008
[TBL] [Abstract][Full Text] [Related]
11. Participation of histaminergic H1 and noradrenergic alpha 1 receptors in orexin A-induced wakefulness in rats.
Shigemoto Y; Fujii Y; Shinomiya K; Kamei C
Brain Res; 2004 Oct; 1023(1):121-5. PubMed ID: 15364026
[TBL] [Abstract][Full Text] [Related]
12. Design and synthesis of conformationally constrained N,N-disubstituted 1,4-diazepanes as potent orexin receptor antagonists.
Coleman PJ; Schreier JD; McGaughey GB; Bogusky MJ; Cox CD; Hartman GD; Ball RG; Harrell CM; Reiss DR; Prueksaritanont T; Winrow CJ; Renger JJ
Bioorg Med Chem Lett; 2010 Apr; 20(7):2311-5. PubMed ID: 20207138
[TBL] [Abstract][Full Text] [Related]
13. REM sleep enhancement and behavioral cataplexy following orexin (hypocretin)-II receptor antisense perfusion in the pontine reticular formation.
Thakkar MM; Ramesh V; Cape EG; Winston S; Strecker RE; McCarley RW
Sleep Res Online; 1999; 2(4):112-20. PubMed ID: 11382892
[TBL] [Abstract][Full Text] [Related]
14. Discovery of [(2R,5R)-5-{[(5-fluoropyridin-2-yl)oxy]methyl}-2-methylpiperidin-1-yl][5-methyl-2-(pyrimidin-2-yl)phenyl]methanone (MK-6096): a dual orexin receptor antagonist with potent sleep-promoting properties.
Coleman PJ; Schreier JD; Cox CD; Breslin MJ; Whitman DB; Bogusky MJ; McGaughey GB; Bednar RA; Lemaire W; Doran SM; Fox SV; Garson SL; Gotter AL; Harrell CM; Reiss DR; Cabalu TD; Cui D; Prueksaritanont T; Stevens J; Tannenbaum PL; Ball RG; Stellabott J; Young SD; Hartman GD; Winrow CJ; Renger JJ
ChemMedChem; 2012 Mar; 7(3):415-24, 337. PubMed ID: 22307992
[TBL] [Abstract][Full Text] [Related]
15. Mapping the binding pocket of dual antagonist almorexant to human orexin 1 and orexin 2 receptors: comparison with the selective OX1 antagonist SB-674042 and the selective OX2 antagonist N-ethyl-2-[(6-methoxy-pyridin-3-yl)-(toluene-2-sulfonyl)-amino]-N-pyridin-3-ylmethyl-acetamide (EMPA).
Malherbe P; Roche O; Marcuz A; Kratzeisen C; Wettstein JG; Bissantz C
Mol Pharmacol; 2010 Jul; 78(1):81-93. PubMed ID: 20404073
[TBL] [Abstract][Full Text] [Related]
16. Orexins depolarize rostral ventrolateral medulla neurons and increase arterial pressure and heart rate in rats mainly via orexin 2 receptors.
Huang SC; Dai YW; Lee YH; Chiou LC; Hwang LL
J Pharmacol Exp Ther; 2010 Aug; 334(2):522-9. PubMed ID: 20494957
[TBL] [Abstract][Full Text] [Related]
17. Orexin receptor antagonists differ from standard sleep drugs by promoting sleep at doses that do not disrupt cognition.
Uslaner JM; Tye SJ; Eddins DM; Wang X; Fox SV; Savitz AT; Binns J; Cannon CE; Garson SL; Yao L; Hodgson R; Stevens J; Bowlby MR; Tannenbaum PL; Brunner J; Mcdonald TP; Gotter AL; Kuduk SD; Coleman PJ; Winrow CJ; Renger JJ
Sci Transl Med; 2013 Apr; 5(179):179ra44. PubMed ID: 23552372
[TBL] [Abstract][Full Text] [Related]
18. The dual orexin receptor antagonist almorexant induces sleep and decreases orexin-induced locomotion by blocking orexin 2 receptors.
Mang GM; Dürst T; Bürki H; Imobersteg S; Abramowski D; Schuepbach E; Hoyer D; Fendt M; Gee CE
Sleep; 2012 Dec; 35(12):1625-35. PubMed ID: 23204605
[TBL] [Abstract][Full Text] [Related]
19. Effects of quercetin on the sleep-wake cycle in rats: involvement of gamma-aminobutyric acid receptor type A in regulation of rapid eye movement sleep.
Kambe D; Kotani M; Yoshimoto M; Kaku S; Chaki S; Honda K
Brain Res; 2010 May; 1330():83-8. PubMed ID: 20303338
[TBL] [Abstract][Full Text] [Related]
20. Orexin receptor antagonism, a new sleep-promoting paradigm: an ascending single-dose study with almorexant.
Hoever P; de Haas S; Winkler J; Schoemaker RC; Chiossi E; van Gerven J; Dingemanse J
Clin Pharmacol Ther; 2010 May; 87(5):593-600. PubMed ID: 20376002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
